Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Recent advances in understanding the pathogenesis of polyglutamine diseases: involvement of molecular chaperones and ubiquitin-proteasome pathway.

Journal of chemical neuroanatomy - 1 Oct 2003

Jana Nihar Ranjan, Nukina Nobuyuki

Abstract excerpt

Polyglutamine diseases consist of a group of familial neurodegenerative disorders caused by expression of proteins containing expanded polyglutamine stretch. Over the past several years, tremendous progress has been made in identifying the molecular mechanisms by which the expanded polyglutamine...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amino Acid Metabolism, Inborn Errors
Share to Cysteine Endopeptidases
Share to Molecular Chaperones

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Multienzyme Complexes

Share to Neurodegenerative Diseases

Share to Proteasome Endopeptidase Complex

Share to Protein Folding

Share to Ubiquitin

Source

Identifiers

PMID: 14599658
DOI: 10.1016/s0891-0618(03)00029-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-14599658-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Recent advances in understanding the pathogenesis of polyglutamine diseases: involvement of molecular chaperones and ubiquitin-proteasome pathway.PMID 14599658Read ↗

Polyglutamine Diseases: Where does Toxicity Come from? What is Toxicity? Where are We Going?Semantic proximity Read ↗

Toward an understanding of polyglutamine neurodegeneration.Semantic proximity Read ↗

The ubiquitin-proteasome pathway in Parkinson's disease and other neurodegenerative diseases.Semantic proximity Read ↗

The ubiquitin-proteasome system and neurodegenerative disorders.Semantic proximity Read ↗

Ubiquitin, cellular inclusions and their role in neurodegeneration.Semantic proximity Read ↗

Mechanism of neurodegenerative disease: role of the ubiquitin proteasome systemSemantic proximity Read ↗

Failure of Ubiquitin Proteasome System: Risk for Neurodegenerative DiseasesSemantic proximity Read ↗

The ubiquitin proteasomal system: a potential target for the management of Alzheimer's diseaseSemantic proximity Read ↗

The pathogenic mechanisms of polyglutamine diseases and current therapeutic strategies.Semantic proximity Read ↗

Proteostasis in striatal cells and selective neurodegeneration in Huntingtonâ€™s diseaseSemantic proximity Read ↗

Polyglutamine (PolyQ) Diseases: Navigating the Landscape of NeurodegenerationSemantic proximity Read ↗

TRIM family proteins: roles in proteostasis and neurodegenerative diseasesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.